Ponatinib exert multiple effects on vascular endothelial cells: possible mechanisms and explanations for the adverse vascular events seen in CML patients treated with ponatinib - Kadzijusufovic, E; Kirchmair, R; Theurl, M (Blood, 2016)
, et al.